Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
iXensor CoROCO:6734 -4.56%49 EV-to-EBITDA is -5.08 as of Sep. 09, 2026. GuruFocus rates ROCO:6734 with a GF Score™ of 49/100 and a GF Value™ of NT$5.41 (Fairly Valued). The stock has 5 warning signs investors should review. Among 516 Medical Devices & Instruments companies, iXensor Co ranks worse than 193798.26% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, iXensor Co's enterprise value is NT$215.42 Mil.
iXensor Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was NT$-42.39 Mil. Therefore, iXensor Co's EV-to-EBITDA for today is -5.08.
The historical rank and industry rank for iXensor Co's EV-to-EBITDA or its related term are showing as below:
ROCO:6734'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -18.29 Med: -6.14 Max: 287.93
Current: -5.08
During the past 10 years, the highest EV-to-EBITDA of iXensor Co was 287.93. The lowest was -18.29. And the median was -6.14.
ROCO:6734's EV-to-EBITDA is ranked worse than 100% of 516
companies
in the Medical Devices & Instruments industry
Industry Median: 13.965
vs ROCO:6734: -5.08
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
iXensor Co's share price for today is NT$5.02.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. iXensor Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was NT$-1.194.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for iXensor Co's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6734 vs ABT, SYK, MDT: EV-to-EBITDA Comparison
For the Medical Devices subindustry, iXensor Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
iXensor Co EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, iXensor Co's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where iXensor Co's EV-to-EBITDA falls into.
iXensor Co's current Enterprise Value is NT$215.42 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. iXensor Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was NT$-42.39 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
iXensor Co (ROCO:6734) has a EV-to-EBITDA of -5.08 as of Sep. 09, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on iXensor Co. According to the industry distribution chart, iXensor Co ranks #999999 out of 516 companies in the Medical Devices & Instruments industry.
Is iXensor Co's EV-to-EBITDA too high?
iXensor Co's current EV-to-EBITDA is -5.08. Based on the distribution chart, iXensor Co ranks #999999 out of 516 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, iXensor Co has a GF Score™ of 49/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does iXensor Co's EV-to-EBITDA compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, iXensor Co ranks #999999 out of 516 companies for EV-to-EBITDA. This places iXensor Co in the lower half of its industry. The industry median EV-to-EBITDA is 13.97. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 13.97, based on 516 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on iXensor Co. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 13.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. iXensor Co's current EV-to-EBITDA is -5.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iXensor Co stock overvalued right now?
Based on GuruFocus' analysis, iXensor Co (ROCO:6734) is currently considered Fairly Valued. The stock's GF Value™ is NT$5.41, compared to a current price of NT$5.02 — trading 7.2% below its estimated fair value. The current EV-to-EBITDA is -5.08. iXensor Co's overall GF Score™ is 49/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For iXensor Co (ROCO:6734), the current EV-to-EBITDA is -5.08 as of Sep. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is iXensor Co (ROCO:6734) Overvalued in 2026?
Based on GuruFocus' analysis, iXensor Co stock appears to be undervalued.
The current stock price of NT$5.02 is trading 7.2% below its estimated GF Value™ of NT$5.41.
GuruFocus considers iXensor Co to be Fairly Valued.
Key valuation signals for ROCO:6734:
EV-to-EBITDA: -5.08
GF Value™: NT$5.41 vs. price of NT$5.02 (7.2% below fair value)
No single metric tells the full story. See the ROCO:6734 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
iXensor Co Ltd is a Taiwan based company involved in research and development, manufacturing and sales of medical equipment. Its PixoTest technology utilizes the lighting and image sensing module of the smartphone or mobile device to detect the color change reaction on the biochemical test strip. This enables the users to monitor their conditions of diabetes, cardiovascular diseases, women health problems, or infectious diseases.
49GF Score
Get the complete analysis for ROCO:6734
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6734 has been successfully added to your 
